Pan-cancer proteogenomics reveals potential drug targets

The Human Tumor Atlas Network charts the roadmap for advancing spatial omics

The NCI Human Tumor Atlas Network (HTAN) has published a cluster of papers intended to advance the framework of spatial omics, the science of profiling morphological and molecular features of human cancers in two and three dimensions.

Baylor, Rice researchers receive $2.3M to develop antibody therapy for metastatic breast cancer

Researchers at Baylor College of Medicine and Rice University received a $2.3 million Breakthrough Award from the Department of Defense Congressionally Directed Medical Research Programs to develop a novel NanoGel antibody therapy that targets ER+ breast cancer that has metastasized to bone.

December 06, 2024

Vol.50 No.45

Clinical Roundup

AKT and EZH2 inhibitors kill TNBCs by hijacking mechanisms of involution

New research on the possibility to kill TNBCs by hijacking signals that normally drive mammary gland involution was released in Nature.

October 11, 2024

Vol.50 No.38

In Brief

John Ashton named associate director for shared resources at Wilmot Cancer Institute

John M. Ashton, associate professor in the department of biomedical genetics, has been promoted from assistant director to associate director of shared resources at the University of Rochester’s Wilmot Cancer Institute.

September 13, 2024

Vol.50 No.34

Clinical Roundup

Serotonin-producing neurons regulate malignancy in ependymoma brain tumors

A study published in Nature reveals the functional relevance of tumor-neuron interactions that regulate the growth of ependymoma brain tumors.

August 02, 2024

Vol.50 No.31

Drugs & Targets

Labcorp, Ultima Genomics collaborate to advance whole genome sequencing applications and oncology testing capabilities

Labcorp announced an expanded collaboration with Ultima Genomics to utilize its UG 100TM sequencing solution and ppmSeqTM technology to explore new whole genome sequencing clinical applications, including molecular residual disease in patients with early-stage solid tumor cancers.

August 02, 2024

Vol.50 No.31

Pan-cancer proteogenomics reveals potential drug targets

YOU MAY BE INTERESTED IN

The Human Tumor Atlas Network charts the roadmap for advancing spatial omics

Baylor, Rice researchers receive $2.3M to develop antibody therapy for metastatic breast cancer

AKT and EZH2 inhibitors kill TNBCs by hijacking mechanisms of involution

John Ashton named associate director for shared resources at Wilmot Cancer Institute

Serotonin-producing neurons regulate malignancy in ependymoma brain tumors

Labcorp, Ultima Genomics collaborate to advance whole genome sequencing applications and oncology testing capabilities

Renew today!

Subscriber content

Never miss an issue!

Login